J Gastrointest Surg24 Feb 2025
In a cohort of 1,129 gastric cancer patients undergoing curative gastrectomy, distinct improvements in conditional survival (CS) were observed over 10 years, particularly in stages II and III. The 5-year disease-specific survival rates consistently increased. Notably, survival rates for disease-specific causes intersected for stage II…
Surg Endosc23 Feb 2025
A significant trend toward minimally invasive esophagectomy (mie) and robotic-assisted minimally invasive esophagectomy (ramie) between 2010 and 2019 has been observed, with open esophagectomies (oe) declining by 52%. Mie utilization rose by 49% and ramie by 704%. Both mie and ramie demonstrated lower 30-day and…
Surg Endosc22 Feb 2025
A post hoc analysis involving 490 gastric cancer patients reveals that high preoperative visceral fat area (VFA) significantly increases the risk of intraoperative adverse events (IAEs) during laparoscopic gastrectomy. Specifically, IAEs occurred in 29% of the high VFA group, compared to 12% in the low…
Int J Surg21 Feb 2025
A new deep learning model utilizing multiphase CT images effectively predicts early recurrence in patients with locally advanced gastric cancer (LAGC). The model, integrated with clinical factors, demonstrated superior performance (AUC: 0.891) compared to previous models. Significant associations were found between higher prediction scores and…
Metabolic and Bariatric Surgery20 Feb 2025
The hiatal sling liver retraction technique has shown promising results in bariatric and upper gastrointestinal surgeries, significantly reducing liver enzyme elevation compared to the traditional Nathanson retractor. Among 1,874 surgeries, only two cases experienced difficulties, with no liver injuries or adverse effects reported. This technique…
Ann Surg Oncol13 Feb 2025
Multiparametric MRI (mpmri) demonstrated superior diagnostic accuracy for restaging locally advanced gastric cancer after neoadjuvant therapy, with significant inter-reader agreement noted. The accuracy for T restaging reached 0.586 for mpmri, outperforming other imaging methods. Importantly, mpmri achieved an area under the curve of 0.879 for…
J Gastrointest Surg11 Feb 2025
A thorough analysis of 150 robotic-assisted minimally invasive esophagectomies reveals an impressive 90% textbook outcome rate. Conducted at a single cancer center, the study involved predominantly clinical stage T3 tumors, with 85% receiving neoadjuvant therapy. Postoperative complications included a low rate of anastomotic leaks and…
BMC Surg10 Feb 2025
A comparative study of cis-cut and retro-cut techniques for gastric tube fabrication in esophageal reconstruction revealed significantly lower rates of postoperative anastomotic leakage (3.9% vs 16.7%) and stricture (15% vs 28.6%) in the retro-cut group. Logistic regression identified the cis-cut method as an independent risk…
Eur J Surg Oncol8 Feb 2025
Advances in endoscopic techniques for treating upper gastrointestinal submucosal tumors (SMTs) are promising, with innovations enhancing diagnosis and therapeutic options. The study evaluates diverse endoscopic strategies and their efficacy, indicating they are minimally invasive and expedite recovery compared to traditional surgery. Despite these advancements, concerns…
Gastrointest Endosc5 Feb 2025
Findings indicate that endoscopic gastrojejunostomy (EGJ) is associated with fewer peri-procedural complications compared to surgical gastrojejunostomy (SGJ) for patients with malignant gastric outlet obstruction. Data from over 20,000 hospitalizations from 2016 to 2020 revealed that EGJ resulted in lower rates of respiratory failure, blood transfusions,…